Jocelyn E. Ray

Oncology

1801 W Taylor St
Chicago, IL 60612

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 3 publications

Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo.

Antitumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo.

Journal: Cancer biology & therapy

Published: October 26, 2021

TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic.

TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic.

Journal: Oncotarget

Published: September 23, 2020

ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.

ONC201 and imipridones: Anti-cancer compounds with clinical efficacy.

Journal: Neoplasia (New York, N.Y.)

Published: August 10, 2020

Showing 1-3 of 3

Last Updated: 09/26/2026